Search research articles
Contact Us
Filters
Showing results (311-320 of 418) with videos related to
Page
of 42
Sort By:
Thescientificworldjournal
|
June 2, 2012
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients
Simona Signoriello, Annalisa Annunziata, Nicola Lama, et al.
The Lancet Regional Health. Europe
|
July 22, 2024
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
The Lancet Regional Health. Europe
|
May 30, 2024
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
Cancer Investigation
|
November 27, 2024
Viral Hepatitis in Western Patients with Advanced Intrahepatic Cholangiocarcinoma: Retrospective Assessment of Prevalence, Prognostic and Predictive Significance
Roberto Filippi, Giovanni Brandi, Andrea Casadei-Gardini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2015
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials
Massimo Di Maio, Ciro Gallo, Natasha B Leighl, et al.
Critical Reviews in Oncology/Hematology
|
January 26, 2020
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018
Pasquale Lombardi, Laura Marandino, Emmanuele De Luca, et al.
Critical Reviews in Oncology/Hematology
|
February 22, 2022
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma
Marco Tagliamento, Paolo Bironzo, Hubert Curcio, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 18, 2019
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018
Maria Lucia Reale, Emmanuele De Luca, Pasquale Lombardi, et al.
BMC Cancer
|
January 10, 2006
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study
Sandro Pignata, Sabino De Placido, Rosalbino Biamonte, et al.
Clinical Pharmacology and Therapeutics
|
February 11, 2026
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data
Francesco Pignatti, Tarec Christoffer El-Galaly, Martin Kaiser, et al.
Page
of 42
Search research articles
Search
Showing results (311-320 of 418) with videos related to
Sort By:
Page
of 42
Thescientificworldjournal
|
June 2, 2012
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients
Simona Signoriello, Annalisa Annunziata, Nicola Lama, et al.
The Lancet Regional Health. Europe
|
July 22, 2024
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
The Lancet Regional Health. Europe
|
May 30, 2024
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]
Maria Lucia Iacovino, Simone Celant, Luca Tomassini, et al.
Cancer Investigation
|
November 27, 2024
Viral Hepatitis in Western Patients with Advanced Intrahepatic Cholangiocarcinoma: Retrospective Assessment of Prevalence, Prognostic and Predictive Significance
Roberto Filippi, Giovanni Brandi, Andrea Casadei-Gardini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2015
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials
Massimo Di Maio, Ciro Gallo, Natasha B Leighl, et al.
Critical Reviews in Oncology/Hematology
|
January 26, 2020
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018
Pasquale Lombardi, Laura Marandino, Emmanuele De Luca, et al.
Critical Reviews in Oncology/Hematology
|
February 22, 2022
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma
Marco Tagliamento, Paolo Bironzo, Hubert Curcio, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 18, 2019
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018
Maria Lucia Reale, Emmanuele De Luca, Pasquale Lombardi, et al.
BMC Cancer
|
January 10, 2006
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study
Sandro Pignata, Sabino De Placido, Rosalbino Biamonte, et al.
Clinical Pharmacology and Therapeutics
|
February 11, 2026
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data
Francesco Pignatti, Tarec Christoffer El-Galaly, Martin Kaiser, et al.
Page
of 42